It’s only been a few days, and already the official transition of power in Washington, D.C., has touched San Diego in concrete ways.
A flurry of executive orders from President Joe Biden’s first 24 hours in office has halted construction on border wall projects, pledged further protection for the county’s 27,000 DACA recipients, and frozen deportation orders for an unknown number of local migrants.
For the record:
3:22 PM, Jan. 24, 2021A previous version of this story incorrectly stated the length of time that U.S. Attorney Robert Brewer has served in office.
The immediate changes, if only temporary, mark the sharp ideological contrast between the Trump and Biden administrations, and are just the beginning of more drastic changes expected in the coming days and weeks.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine
Gritstone Oncology, IncJanuary 20, 2021 GMT Deal provides nonexclusive access to Genevant’s leading LNP technology for use in Gritstone’s self-amplifying RNA COVID-19 vaccine program; NIH-sponsored Phase 1 clinical trial expected to initiate in 1Q21 Agreement is the second between the parties since October 2020
EMERYVILLE, Calif. and VANCOUVER, British Columbia and BASEL, Switzerland , Jan. 20, 2021 (GLOBE NEWSWIRE) Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, and Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate, today announced an agreement pursuant to whi
E-Mail
IMAGE: People with severe COVID-19 manifestations may be left with more of the protective memory T cells needed to fight reinfection. view more
Credit: La Jolla Institute for Immunology
LA JOLLA, CA A big question on people s minds these days: how long does immunity to SARS-CoV-2 last following infection?
Now a research team from La Jolla Institute for Immunology (LJI), The University of Liverpool and the University of Southampton has uncovered an interesting clue. Their new study suggests that people with severe COVID-19 cases may be left with more of the protective memory T cells needed to fight reinfection. The data from this study suggest people with severe COVID-19 cases may have stronger long-term immunity, says study co-leader LJI Professor Pandurangan Vijayanand, M.D., Ph.D.
Gritstone Oncology, a biotech firm developing vaccines, has announced that it is advancing the development of a second generation vaccine against Covid-19.
Guía definitiva para desmentir bulos sobre el SARS-CoV-2 y la COVID-19 diariodenavarra.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from diariodenavarra.es Daily Mail and Mail on Sunday newspapers.